Suchergebnisse - "Akkerman, O.W."

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network von Migliori, Giovanni Battista, Tiberi, Simon, Zumla, Alimuddin, Petersen, Eskild, Chakaya, Jeremiah Muhwa, Wejse, Christian, Muñoz Torrico, Marcela, Duarte, Raquel, Alffenaar, Jan Willem, Schaaf, H. Simon, Marais, Ben J., Cirillo, Daniela Maria, Alagna, Riccardo, Rendon, Adrian, Pontali, Emanuele, Piubello, Alberto, Figueroa, José, Ferlazzo, Gabriella, García-Basteiro, Alberto, Centis, Rosella, Visca, Dina, D’Ambrosio, Lia, Sotgiu, Giovanni, Arkub, T. Abu, Akkerman, O.W., Aleksa, A., Belilovski, E., Bernal, E., Blanc, F-X., Boeree, M., Borisov, S., Bruchfeld, J., Cadiñanos Loidi, J., Caminero, J.A., Carvalho, A.C., Cebrian Gallardo, J.J., Charalampos, Danila, E., Davies Forsman, L., Denholm, J., Dheda, K., Diel, R., Diktanas, S., Dobler, C., Enwerem, M., Esposito, S., Escobar Salinas, N., Filippov, A., Formenti, B., García García, J.M., Goletti, D., Gomez Rosso, R., Gualano, G., Isaakidis, P., Kaluzhenina, A., Koirala, S., Kuksa, L., Kunst, H., Li, Y., Magis-Escurra, C., Manfrin, V., Manga, S., Manika, K., Marchese, V., Martínez Robles, E., Maryandyshev, A., Matteelli, A., Mariani, A., Mazza-Stalder, J., Mello, F., Mendoza, L., Mesi, A., Miliauskas, S., Mustafa Hamdan, H., Ndjeka, N., Nieto Marcos, M., Ottenhoff, T.H.M., Palmero, D.J., Palmieri, F., Papavasileiou, A., Payen, M.C., Pontarelli, A., Pretti Dalcolmo, M., Quirós Fernandez, S., Romero, R., Rossato Silva, D., Santos, A.P., Seaworth, B., Sinitsyn, M., Skrahina, A., Solovic, I., Spanevello, A., Tadolini, M., Torres, C., Udwadia, Z., van den Boom, M., Volchenkov, G.V., Yedilbayev, A., Zaleskis, R., Zellweger, J.P.

“… •Updated clinical guidance on MDR-TB is needed.•Several new MDR-TB diagnostics have been recently approved by WHO to complement existing tools.•To design a …”
Volltext

Measurement of isoniazid in tuberculosis patients using finger sweat with creatinine normalisation: A controlled administration study von Longman, K., Akkerman, O.W., Ghimire, S., Bolhuis, M.S., Chambers, M.A., Sturkenboom, M.G.G., Bailey, M.J.

“… •Ensuring adherence and sufficient exposure to anti-tuberculosis medications is essential for successful treatment.•Finger sweat offers a non-invasive …”
Volltext

WS01.03 Effects of elexacaftor/tezacaftor/ivacaftor in lung transplant recipients with cystic fibrosis: the Dutch national KOALA study von van Gemert, J.P, Luijk, B, Hellemons, M.E, Visser, K.A, Hansen, C, Meer, R. van der, Gan, T, Vaart, H. van der, Akkerman, O.W, Steenhuis, W.N, Verkleij, M, Heijerman, H.G.M, Verschuuren, E.A.M

Volltext

TB treatment support strategies for children, adolescents, and young adults in a low-incidence setting von Verhage, A.R., Hesseling, A.C., Koppelman, G.H., Kerstjens, H.A.M., Akkerman, O.W.

“… BACKGROUND Globally, TB programmes should pay attention to the treatment support needs of children and adolescents (0-24 years) given the high disease burden …”
Volltext

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort von Koirala, S., Borisov, S., Danila, E., Mariandyshev, A., Shrestha, B., Lukhele, N., Dalcolmo, M., Shakya, S.R., Miliauskas, S., Kuksa, L., Manga, S., Aleksa, A., Denholm, J.T., Khadka, H.B., Skrahina, A., Diktanas, S., Ferrarese, M., Bruchfeld, J., Koleva, A., Piubello, A., Koirala, G.S., Udwadia, Z.F., Palmero, D.J., Munoz-Torrico, M., GC, R., Gualano, G., Grecu, V.I., Motta, I., Papavasileiou, A., Li, Y., Hoefsloot, W., Kunst, H., Mazza-Stalder, J., Payen, M.-C., Akkerman, O.W., Bernal, E., Manfrin, V., Matteelli, A., Mustafa Hamdan, H., Nieto Marcos, M., Cadiñanos Loidi, J., Cebrian Gallardo, J.J., Duarte, R., Escobar Salinas, N., Gomez Rosso, R., Laniado-Laborín, R., Martínez Robles, E., Quirós Fernandez, S., Rendon, A., Solovic, I., Tadolini, M., Viggiani, P., Belilovski, E., Boeree, M.J., Cai, Q., Davidavičienė, E., Forsman, L.D., De Los Rios, J., Drakšienė, J., Duga, A., Elamin, S.E., Filippov, A., Garcia, A., Gaudiesiute, I., Gavazova, B., Gayoso, R., Gruslys, V., Jonsson, J., Khimova, E., Madonsela, G., Magis-Escurra, C., Marchese, V., Matei, M., Moschos, C., Nakčerienė, B., Nicod, L., Palmieri, F., Pontarelli, A., Šmite, A., Souleymane, M.B., Vescovo, M., Zablockis, R., Zhurkin, D., Alffenaar, J.-W., Caminero, J.A., Codecasa, L.R., García-García, J.-M., Esposito, S., Saderi, L., Spanevello, A., Visca, D., Tiberi, S., Pontali, E., Centis, R., D'Ambrosio, L., van den Boom, M., Sotgiu, G., Migliori, G.B.

“… The World Health Organization (WHO) recommends countries introduce new anti-TB drugs in the treatment of multidrug-resistant tuberculosis. The aim of the study …”
Volltext

Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis von Dijkstra, J.A., van Altena, R., Akkerman, O.W., de Lange, W.C.M., Proost, J.H., van der Werf, T.S., Kosterink, J.G.W., Alffenaar, J.W.C.

“… •Amikacin and kanamycin are both used in the treatment of multidrug-resistant tuberculosis.•One combined model was designed based on the pooled data of all 30 …”
Volltext

Hope rises out of despair: bedaquiline and linezolid for the treatment of drug-resistant TB von Furin, J, Akkerman, O W

Weitere Angaben

A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs von Cevik, M, Sturdy, A, Maraolo, A E, Dekkers, B G J, Akkerman, O W, Gillespie, S H, Alffenaar, J W C

“… OBJECTIVESThe coexistence of TB and diabetes mellitus (DM) (TB-DM) is associated with an increased risk of treatment failure, death, delayed culture …”
Weitere Angaben

The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: A multicenter experience von Roosma, Elizabeth, van Gemert, Johanna P, de Zwart, Auke E S, van Leer-Buter, Coretta C, Hellemons, Merel E, Berg, Elize M, Luijk, Bart, Hoek, Rogier A S, van Kessel, Diana A, Akkerman, Onno W, Kerstjens, Huib A M, Verschuuren, Erik A M, Gan, C Tji

“… Concerns have been raised on the impact of coronavirus disease (COVID-19) on lung transplant (LTx) patients. The aim of this study was to evaluate the …”
Weitere Angaben

Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort study von Pradipta, I S, Van't Boveneind-Vrubleuskaya, N, Akkerman, O W, Alffenaar, J W C, Hak, E

“… We evaluated treatment outcomes and predictors for poor treatment outcomes for tuberculosis (TB) among native- and foreign-born patients with drug-susceptible …”
Weitere Angaben

Artificial intelligence for TB education and counselling: a modified Delphi consensus von Ngiam, J N, Koh, M C Y, D'Ambrosio, L, Goletti, D, Denholm, J T, Akkerman, O W, Centis, R, Dinh-Xuan, A T, Pontali, E, Torrico, M M, Garcia-Basteiro, A L, Schaaf, H S, Migliori, G B, Ong, C W M

“… BACKGROUNDOptimal TB care and control requires improved health education and effective patient counselling. Effective counselling is a lengthy process that …”
Weitere Angaben

The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family von Hoppentocht, M., Akkerman, O.W., Hagedoorn, P., Frijlink, H.W., de Boer, A.H.

“… [Display omitted] •Aminoglycosides are hygroscopic drugs with poor dispersion and retention properties.•Tobramycin moisture sorption is much higher for the …”
Volltext

Epidemiology and management of nontuberculous mycobacterial disease in people with cystic fibrosis, the Netherlands von Zomer, Domenique, van Ingen, Jakko, Hofland, Regina, Akkerman, O.W., Altenburg, J., Bakker, M., Bannier, M.A.G.E., Conemans, L.H., Gulmans, V.A.M., Heijerman, H.G.M., Hoek, R.A.S., Janssens, H.M., van der Meer, R., Merkus, P.J.F.M., Noordhoek, J.J., Nuijsink, M., Terheggen-Lagro, S.W.J., van der Vaart, H., de Winter-de Groot, K.M.

“… •Nontuberculous mycobacteria (NTM) prevalence increased in people with CF in the Netherlands.•M. abscessus is the most frequent variant.•More than half of NTM …”
Volltext

Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q von Niewold, P., Dijkstra, D.J., Cai, Y., Goletti, D., Palmieri, F., Meijgaarden, K.E. van, Verreck, F.A.W., Akkerman, O.W., Hofland, R.W., Delemarre, E.M., Nierkens, S., Verheul, M.K., Pollard, A.J., Dissel, J.T. van, Ottenhoff, T.H.M., Trouw, L.A., Joosten, S.A.

“… Tuberculosis (TB) is a prevalent disease causing an estimated 1.6 million deaths and 10.6 million new cases annually. Discriminating TB disease from …”
Volltext

Drugs during pregnancy and breast feeding in women diagnosed with Cystic Fibrosis - An update von Kroon, M.A.G.M., Akkerman-Nijland, A.M., Rottier, B.L., Koppelman, G.H., Akkerman, O.W., Touw, D.J.

Volltext

The long-term safety of chronic azithromycin use in adult patients with cystic fibrosis, evaluating biomarkers for renal function, hepatic function and electrical properties of the heart von Akkerman-Nijland, A.M., Möhlmann, J.E., Akkerman, O.W., Vd Vaart, H., Majoor, C.J., Rottier, B.L., Burgerhof, J.G.M., Hak, E., Koppelman, G.H., Touw, D.J.

“… Background: Azithromycin maintenance therapy is widely used in cystic fibrosis (CF), but little is known about its long-term safety. We investigated whether …”
Volltext

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort von S. Koirala, S. Borisov, E. Danila, A. Mariandyshev, B. Shrestha, N. Lukhele, M. Dalcolmo, S.R. Shakya, S. Miliauskas, L. Kuksa, S. Manga, A. Aleksa, J.T. Denholm, H.B. Khadka, A. Skrahina, S. Diktanas, M. Ferrarese, J. Bruchfeld, A. Koleva, A. Piubello, G.S. Koirala, Z.F. Udwadia, D.J. Palmero, M. Munoz-Torrico, R. Gc, G. Gualano, V.I. Grecu, I. Motta, A. Papavasileiou, Y. Li, W. Hoefsloot, H. Kunst, J. Mazza-Stalder, M.-C. Payen, O.W. Akkerman, E. Bernal, V. Manfrin, A. Matteelli, H. Mustafa Hamdan, M. Nieto Marcos, J. Cadiñanos Loidi, J.J. Cebrian Gallardo, R. Duarte, N. Escobar Salinas, R. Gomez Rosso, R. Laniado-Laborín, E. Martínez Robles, S. Quirós Fernandez, A. Rendon, I. Solovic, M. Tadolini, P. Viggiani, E. Belilovski, M.J. Boeree, Q. Cai, E. Davidavičienė, L.D. Forsman, J. De Los Rios, J. Drakšienė, A. Duga, S.E. Elamin, A. Filippov, A. Garcia, I. Gaudiesiute, B. Gavazova, R. Gayoso, V. Gruslys, J. Jonsson, E. Khimova, G. Madonsela, C. Magis-Escurra, V. Marchese, M. Matei, C. Moschos, B. Nakčerienė, L. Nicod, F. Palmieri, A. Pontarelli, A. Šmite, M.B. Souleymane, M. Vescovo, R. Zablockis, D. Zhurkin, J.-W. Alffenaar, J.A. Caminero, L.R. Codecasa, J.-M. García-García, S. Esposito, L. Saderi, A. Spanevello, D. Visca, S. Tiberi, E. Pontali, R. Centis, L. D'Ambrosio, M. van den Boom, G. Sotgiu, G.B. Migliori

“… The World Health Organization (WHO) recommends countries introduce new anti-TB drugs in the treatment of multidrug-resistant tuberculosis.The aim of the study …”
Volltext